Hisamitsu Pharmaceutical Co., Inc. (TYO:4530)
Japan
· Delayed Price · Currency is JPY 4,005.00
-5.00 (-0.12%)
Jul 8, 2025, 3:30 PM JST
TYO:4530 Revenue
In the fiscal year ending February 28, 2025, Hisamitsu Pharmaceutical Co. had annual revenue of 156.01B JPY with 10.09% growth. Hisamitsu Pharmaceutical Co. had revenue of 44.75B in the quarter ending February 28, 2025, with 15.11% growth.
Revenue
156.01B
Revenue Growth
+10.09%
P/S Ratio
1.88
Revenue / Employee
55.74M
Employees
2,799
Market Cap
292.58B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Feb 28, 2025 | 156.01B | 14.30B | 10.09% |
| Feb 29, 2024 | 141.71B | 13.38B | 10.42% |
| Feb 28, 2023 | 128.33B | 8.14B | 6.77% |
| Feb 28, 2022 | 120.19B | 5.68B | 4.96% |
| Feb 28, 2021 | 114.51B | -26.48B | -18.78% |
| Feb 29, 2020 | Pro | Pro | Pro |
| Feb 28, 2019 | Pro | Pro | Pro |
| Feb 28, 2018 | Pro | Pro | Pro |
| Feb 28, 2017 | Pro | Pro | Pro |
| Feb 29, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,222.12B |
| Takeda Pharmaceutical Company | 4,581.55B |
| Daiichi Sankyo Company | 1,886.26B |
| HOYA Corporation | 866.03B |
| Terumo | 1,036.17B |
| Otsuka Holdings | 2,393.18B |
| Astellas Pharma | 1,912.32B |
| Shionogi & | 438.27B |